August 26, 2025
Hepatitis B is a viral infection that inflames the liver and can lead to chronic disease, cirrhosis, or even liver cancer. Transmitted through blood, bodily fluids, or from mother to newborn, hepatitis B is a global health concern, yet with vaccination, early diagnosis, and treatment, it is manageable and preventable. In this blog, you’ll learn about hepatitis B causes, symptoms, risk factors, special considerations for pregnant women and newborns, diagnosis, treatment options, lifestyle adjustments, and cutting-edge research happening in the UAE and beyond.
The Hepatitis B virus (HBV) is a DNA virus that infects the liver and causes a disease known as hepatitis B. It belongs to the Hepadnaviridae family and is one of the most serious types of hepatitis.
Once inside the body, HBV targets liver cells (hepatocytes), where it multiplies and triggers an immune response. In some individuals, this immune response successfully clears the virus—leading to full recovery and long-term immunity. However, in others, particularly infants and those with weak immune systems, the infection can become chronic, leading to long-term complications like cirrhosis, liver failure, or liver cancer.
Key characteristics of the hepatitis B virus include:
The presence of hepatitis B surface antigen (HBsAg) in the blood indicates an active infection. Additional markers like hepatitis B e antigen (HBeAg) and hepatitis B DNA levels help determine how contagious the person is and guide treatment decisions.
Thanks to widespread hepatitis B vaccination, many countries, including the UAE, have seen dramatic declines in new infections. However, chronic hepatitis B remains a global health concern, especially in regions with lower vaccination coverage or poor access to medical care.
“New to the topic? Explore detailed insights on Hepatitis A”
A small percentage of people become chronic hepatitis B carriers, remaining contagious even without symptoms.
A Hepatitis B carrier is someone who has been infected with the hepatitis B virus (HBV) and continues to have the virus present in their blood for more than six months even without symptoms. This means the virus is still in their system, even if they don’t have any symptoms or liver damage. Carriers are often identified by the continued presence of the hepatitis B surface antigen (HBsAg) in their blood. Some carriers also test positive for hepatitis B e antigen (HBeAg) or HBV DNA, which may indicate that the virus is active and they are more likely to spread it to others.
Yes. Even if someone doesn’t have symptoms, a hepatitis B carrier can transmit the virus through:
Though being a carrier can sound alarming, many people live full, healthy lives with proper care, lifestyle adjustments, and regular medical follow-ups.
Most people are asymptomatic in the early stages. If symptoms appear, they may include:
If you believe you’ve been exposed to the hepatitis B virus (HBV), through unprotected sex, shared needles, contact with infected blood, or travel to high-risk areas, it’s essential to book a consultation with a gastroenterologist and get tested promptly.
Your doctor will request one or more of the following tests and will explain what each of them indicates about your case:
Test Type | What It Assesses |
HBsAg & HBeAg Antigens | Detects active infection; an antigen positive means contagious |
Anti-HBc, Anti-HBe, Anti-HBs | Antibodies indicating past exposure (core antibody), lower infectivity, or immunity |
HBV DNA PCR | Measures viral load—key for staging and treatment decisions |
Liver Enzymes & Bilirubin | Assess inflammation and liver function |
Ultrasound / FibroScan | Checks for fibrosis, cirrhosis, and liver structural health |
False positive tests occasionally occur; that’s why doctors assess the test results and may request you to repeat some of them or do further tests to confirm the diagnosis before treatment.
Regular monitoring of your hepatitis B antibody titer confirms whether vaccination produced immunity (anti-HBs >10 mIU/mL is the normal range).
Standard schedule: 0, 1, 6 months (three doses), hepatitis B doses for adults and newborns
Baby vaccine: Administered within 12 hours of birth, essential to prevent vertical transmission
Booster needed? Generally, no for healthy individuals, but immunocompromised may benefit
Antibody titer testing after vaccination ensures protection; if low (out of range), booster is advised
Phase | Treatment Approach |
Acute | Supportive care; most adults clear the virus naturally |
Chronic (inactive carrier) | Regular blood work and scanning; no immediate drug treatment unless liver damage develops |
Chronic active infection | Long-term antivirals to suppress HBV DNA and reduce liver damage and complications |
Advanced disease | Possible liver transplant or combination therapy depending on fibrosis/cirrhosis |
Novel therapies include:
Rare but serious hepatitis B complications include:
Early detection and antiviral suppression are proven to lower these risks significantly.